What is the route of administration of the pentavalent vaccine?

DSSSB 13 August 2024

Nursing Foundation

Easy

Appeared in: DSSSB 13 August 2024

Explanation

The pentavalent vaccine is administered via the intramuscular (IM) route.
This is a critical requirement because the vaccine contains an aluminum adjuvant, a substance added to boost the immune response.
IM injection into deep muscle tissue is necessary to prevent severe local adverse reactions, such as sterile abscesses and granulomas, which can occur if adjuvanted vaccines are given subcutaneously or intradermally.
The muscle's high vascularity ensures efficient absorption of the vaccine and presentation to the immune system.

Option A: The intradermal route involves injecting into the topmost layer of the skin. This route is not used for the pentavalent vaccine as the adjuvant would cause a severe local inflammatory reaction.
Option B: Intravenous administration introduces the vaccine directly into the bloodstream, which can cause severe systemic reactions and does not create the localized 'depot' effect needed for an effective and sustained immune response.
Option D: The subcutaneous route injects the vaccine into the fatty tissue beneath the skin. For an adjuvanted vaccine like pentavalent, this route is contraindicated as it can lead to intense local inflammation, pain, and the formation of sterile abscesses.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Route of administration for pentavalent vaccine as background academic context rather than a clinical decision trigger.
Adhering to the correct administration route is a fundamental nursing responsibility for ensuring vaccine efficacy and patient safety. An incorrect route can lead to vaccine failure or severe adverse events.
For infants and toddlers, the recommended site for IM injection of the pentavalent vaccine is the anterolateral aspect of the mid-thigh, as the vastus lateralis muscle is well-developed and away from major nerves and blood vessels.
What if? If a nurse accidentally administers the pentavalent vaccine subcutaneously, the patient must be monitored closely for signs of a severe local reaction (e.g., induration, sterile abscess). The event must be documented as a medication error, and the primary healthcare provider should be notified. The vaccine's immunogenicity may be reduced, potentially requiring revaccination.

How to Approach the Question

This is a factual recall question based on the national immunization schedule and standard nursing practice.
First, identify the vaccine in question: Pentavalent vaccine.
Recall its key characteristic: it is an adjuvanted vaccine (containing components like DPT and HepB).
Apply the general rule for vaccine administration: Adjuvanted vaccines must be given intramuscularly (IM) to prevent local reactions.
Systematically eliminate the other options. Intradermal (ID) is for BCG. Subcutaneous (SC) is for live vaccines like MMR. Intravenous (IV) is never used for vaccines.
Select 'Intra-muscular' as the only safe and effective route.

Concept Tested & Keywords

QR9gksE7mnQDj0Vk8HnLQ4

E6 Parks TextBook of Preventive & Social Medicine part 1 — Subpart A (pp 26-201 of 604) p. 99-101

E6 Ghai Essential Pediatrics(pp 26-904 of 913) p. 187-189